The FDA has, on 25 October 2013, approved Zohydro ER (hydrocodone bitartrate extended-release capsules) from Zogenix, for the management of...
The FDA has approved a new formulation of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, from Zogenix, with BeadTek, for the...
The FDA has accepted for review the new drug application (NDA) for the oral, extended-release hydrocodone therapy ZohydroER from Zogenix...
Zogenix, Inc. has announced it has submitted to the FDA a supplemental New Drug Application (sNDA) for a modified formulation...
Zogenix, Inc. announced today that it has entered into a definitive agreement to sell its Zohydro ER (hydrocodone bitartrate) business...
The FDA Anasthetic and Analgesic Advisory Committee found Zohydro (hydrocodone bitartrate extended-release capsules)from Zogenix, was effective in managing Moderate to...
Zogenix has submitted an New Drug Application (NDA) to the FDA for Zohydro (hydrocodone bitartrate extended-release capsules) for the treatment...
The Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee of the FDA voted...
Egalet Corporation has announced that the FDA has approved Arymo ER (morphine sulfate) extended-release (ER) tablets C-II for the management...
Endo International plc continues to believe in the safety, efficacy, and favorable benefit-risk profile of Opana ER (oxymorphone hydrochloride extended...